Loading....
Saturday, April 26, 2025
11:30 AM CDT - 12:30 PM CDT
WEBINAR DESCRIPTION
In this webinar, Dr. David Sallman will discuss the diagnosis of MDS and MPN, treatment options available to patients and symptom management. Questions can be submitted in advance to help@aamds.org.
Thank you to our 2025 Sponsors.
Diamond Level
Silver Level
Bronze Level
WEBINAR FACULTY
Dr. David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr. Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and II clinical trials) for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), based on the underlying mutational drivers of each disease.
Thank you for registering for this webinar.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email clark@aamds.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.